Last reviewed · How we verify
mOPV2 at 6 and 10 weeks of age — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
mOPV2 at 6 and 10 weeks of age (mOPV2 at 6 and 10 weeks of age) — Centers for Disease Control and Prevention.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| mOPV2 at 6 and 10 weeks of age TARGET | mOPV2 at 6 and 10 weeks of age | Centers for Disease Control and Prevention | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- mOPV2 at 6 and 10 weeks of age CI watch — RSS
- mOPV2 at 6 and 10 weeks of age CI watch — Atom
- mOPV2 at 6 and 10 weeks of age CI watch — JSON
- mOPV2 at 6 and 10 weeks of age alone — RSS
Cite this brief
Drug Landscape (2026). mOPV2 at 6 and 10 weeks of age — Competitive Intelligence Brief. https://druglandscape.com/ci/mopv2-at-6-and-10-weeks-of-age. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab